Latest News & Updates
Breaking News
1 day ago
Simantini Singh Deo
Other trending news you may like to read
GRI Bio Releases 6-Week Interim Lung Function Results From Ongoing Phase 2a Clinical Study In Idiopathic Pulmonary Fibrosis (IPF)
GRI Bio’s GRI-0621 shows no FVC decline and anti-fibrotic biomarker signals in Phase 2a IPF study six-week data.
Simantini Singh Deo
OSE Immunotherapeutics & FoRT Foundation Complete Enrollment For Combi-TED Phase 2 Trial Testing Tedopi® With Nivolumab Or Docetaxel In Non-Small Cell Lung Cancer Patients
OSE Immunotherapeutics and FoRT complete enrollment in Combi-TED Phase 2 trial of Tedopi combos for metastatic NSCLC.
Simantini Singh Deo
Immix Biopharma Appoints Renowned Biotech Leader And Former Tanox CEO Nancy T. Chang To Board of Directors Following Her Goose Capital Investment
Immix Biopharma adds biotech leader Nancy T. Chang to its Board, boosting strategy for advanced cell therapy programs.
Simantini Singh Deo
Nacuity Pharmaceuticals Reports Positive Clinical Trial Results For NPI-001 In Treating Retinitis Pigmentosa Linked To Usher Syndrome
Nacuity’s SLO-RP trial shows NPI-001 slowed photoreceptor loss by 50% in Usher-related retinitis pigmentosa over two years.
Simantini Singh Deo
